OC
CELG

Oakworth Capital’s Celgene Corp CELG Stock Holding History

Oakworth Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-217
Closed -$22K – 601
2019
Q3 		$22K Sell
217
-524
-71% -$49.8K ﹤0.01% 364
2019
Q2 		$68K Buy
741
+53
+8% +$5.03K 0.01% 283
2019
Q1 		$65K Hold
688
– – 0.01% 274
2018
Q4 		$44K Buy
688
+50
+8% +$3.69K 0.01% 302
2018
Q3 		$57K Sell
638
-300
-32% -$26.5K 0.01% 285
2018
Q2 		$75K Buy
938
+20
+2% +$1.66K 0.02% 249
2018
Q1 		$80K Sell
918
-144
-14% -$13.8K 0.02% 232
2017
Q4 		$107K Sell
1,062
-200
-16% -$22.6K 0.03% 211
2017
Q3 		$175K Buy
1,262
+46
+4% +$6.27K 0.04% 172
2017
Q2 		$158K Buy
1,216
+127
+12% +$15.6K 0.04% 177
2017
Q1 		$136K Buy
1,089
+412
+61% +$49.3K 0.04% 187
2016
Q4 		$80K Hold
677
– – 0.03% 227
2016
Q3 		$71K Buy
677
+35
+5% +$3.79K 0.02% 219
2016
Q2 		$68K Buy
642
+200
+45% +$20.7K 0.03% 220
2016
Q1 		$44K Buy
442
+300
+211% +$30.9K 0.02% 222
2015
Q4 		$17K Buy
142
+30
+27% +$3.47K 0.01% 311
2015
Q3 		$12K Hold
112
– – 0.01% 290
2015
Q2 		$15K Hold
112
– – 0.01% 283
2015
Q1 		$12K Hold
112
– – 0.01% 308
2014
Q4 		$13K Hold
112
– – 0.01% 303
2014
Q3 		$11K Buy
112
+56
+100% +$5.05K 0.01% 283
2014
Q2 		$5K Sell
56
-56
-50% -$4.26K ﹤0.01% 341
2014
Q1 		$8K Hold
112
– – 0.01% 300
2013
Q4 		$9K Buy
+112
New +$8.86K 0.01% 277

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Oakworth Capital's CELG Position: Q4 2019 in Review

Oakworth Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 217 shares — an estimated $22K sold.

Oakworth Capital first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $175K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oakworth Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oakworth Capital sold 217 Celgene Corp shares in Q4 2019, an estimated $22K.
  • Oakworth Capital first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Oakworth Capital's Celgene Corp position peaked at $175K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oakworth Capital's 13F filing for Q4 2019, filed 31 Jan 2020.